"Genelabs AIDS Drug Safe in Clinical Tests"

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

"Genelabs AIDS Drug Safe in Clinical Tests"

Investor's Business Daily (12/17/91), P. 30

Abstract: Genelabs Technologies Inc. said yesterday that its treatment for AIDS, GLQ223, has proven safe and clinically well-tolerated in its Phase I results. Genelabs said the clinical study showed that GLQ223, or alpha-trichosanthin, was effective when given to AIDS patients or those with AIDS-related complex. The drug was well tolerated and was linked with measurable increases in markers of immunological activity. Twenty-one patients with AIDS or ARC were administered four weekly infusions of GLQ223. According to the company, the patients with the two highest doses experienced the best results in immunologic markers. The Phase II trial started in September and will comapare and combine GLQ223 with AZT.

911217
AD912246

Copyright © 1991 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.